Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Achieve TMS Centers is a specialized healthcare provider focused on Transcranial Magnetic Stimulation (TMS) therapy, a non-invasive neuromodulation treatment for mental health disorders. The company primarily serves patients with treatment-resistant depression and obsessive-compulsive disorder (OCD) who have not found relief through traditional medication or psychotherapy. Utilizing advanced Deep TMS technology, Achieve TMS operates a network of clinical centers across the United States, particularly in California, Oregon, and Alaska. In 2019, the company was acquired by Greenbrook TMS, a leading provider of TMS therapy in North America, to expand its clinical footprint and service capabilities. The centers are staffed by board-certified psychiatrists and trained technicians dedicated to providing evidence-based psychiatric care.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Achieve TMS Centers.